The Blood-Brain Barrier as a Target in Traumatic Brain Injury Treatment

Archives of Medical Research

Volumn 45, Issue 8, 2014, Pages 698-710

  Thal, Serge C ^a   Neuhaus, Winfried ^b,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Blood brain barrier; Brain injury; Immune cells; Neuronal inflammation

Indexed keywords

BORTEZOMIB; DEXAMETHASONE; FENOFIBRATE; GLUCOCORTICOID RECEPTOR; MYOSIN LIGHT CHAIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIOGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; NEUROPROTECTIVE AGENT; ROSIGLITAZONE;

BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN EDEMA; BRAIN HYPOXIA; DISEASE CLASSIFICATION; DISEASE MODEL; HIPPOCAMPUS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN PHOSPHORYLATION; REVIEW; TRAUMATIC BRAIN INJURY; AGONISTS; BRAIN INJURIES; CELL HYPOXIA; DRUG EFFECTS; INFLAMMATION; METABOLISM; NEURODEGENERATIVE DISEASES; PATHOLOGY; PHYSIOLOGY;

BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURIES; CELL HYPOXIA; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; MYOSIN-LIGHT-CHAIN KINASE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RECEPTORS, GLUCOCORTICOID; THIAZOLIDINEDIONES;

EID: 84924799212     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.11.006     Document Type: Review

References (143)

1. Baethmann A., Wirth A., Schlesinger-Raab A. Prospective system analysis of the pre- and early hospital care in severe head injury in Bavaria at a population-based level. Eur Surg Res 2002, 34:42-46.
2. Berg J., Tagliaferri F., Servadei F. Cost of trauma in Europe. Eur J Neurol 2005, 12(suppl 1):85-90.
3. Langlois J.A., Rutland-Brown W., Wald M.M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006, 21:375-378.
4. Teasdale G., Jennett B. Assessment and prognosis of coma after head injury. Acta Neurochir (Wien) 1976, 34:45-55.
5. Willeumier K., Pulst S.M., Schweizer F.E. Proteasome inhibition triggers activity-dependent increase in the size of the recycling vesicle pool in cultured hippocampal neurons. J Neurosci 2006, 26:11333-11341.
6. Bratton S.L., Chestnut R.M., Ghajar J., et al. Guidelines for the management of severe traumatic brain injury. XV. Steroids. J Neurotrauma 2007, 24(suppl 1):S91-S95. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS.
7. Joó F. Endothelial cells of the brain and other organ systems: some similarities and differences. Prog Neurobiol 1996, 48:255-273.
8. Förster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 2008, 130:55-70.
9. Piontek J., Fritzsche S., Cording J., et al. Elucidating the principles of the molecular organization of heteropolymeric tight junction strands. Cell Mol Life Sci 2011, 68:3903-3918.
10. Butt A.M., Jones H.C., Abbott N.J. Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study. J Physiol 1990, 429:47-62.
11. Walsh T.G., Murphy R.P., Fitzpatrick P., et al. Stabilization of brain microvascular endothelial barrier function by shear stress involves VE-cadherin signaling leading to modulation of pTyr-occludin levels. J Cell Physiol 2011, 226:3053-3063.
12. Abbott N.J., Rönnbäck L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
13. Neuhaus W., Noe C.R. Transport at the blood-brain barrier. Transporters as Drug Carriers 2009, 263-298. Wiley-VCH Verlag GmbH & Co, Weinheim, Germany. G.F. Ecker, P. Chiba (Eds.).
14. Abbott N.J., Patabendige A.A., Dolman D.E., et al. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37:13-25.
15. Obermeier B., Daneman R., Ransohoff R.M. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013, 19:1584-1596.
16. Miyamoto N., Pham L.D., Seo J.H., et al. Crosstalk between cerebral endothelium and oligodendrocyte. Cell Mol Life Sci 2014, 71:1055-1066.
17. Daneman R. The blood-brain barrier in health and disease. Ann Neurol 2012, 72:648-672.
18. Krizanac-Bengez L., Mayberg M.R., Janigro D. The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology. Neurol Res 2004, 26:846-853.
19. Stanimirovic D.B., Friedman A. Pathophysiology of the neurovascular unit: disease cause or consequence?. J Cereb Blood Flow Metab 2012, 32:1207-1221.
20. David Y., Cacheaux L.P., Ivens S., et al. Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?. J Neurosci 2009, 29:10588-10599.
21. Aihara N., Hall J.J., Pitts L.H., et al. Altered immunoexpression of microglia and macrophages after mild head injury. J Neurotrauma 1995, 12:53-63.
22. Stamatovic S.M., Dimitrijevic O.B., Keep R.F., et al. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl 2006, 96:444-450.
23. Shlosberg D., Benifla M., Kaufer D., et al. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010, 6:393-403.
24. Pop V., Badaut J. A neurovascular perspective for long-term changes after brain trauma. Transl Stroke Res 2011, 2:533-545.
25. Ivens S., Kaufer D., Flores L.P., et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 2007, 130:535-547.
26. Hutchinson P.J., O'Connell M.T., Rothwell N.J., et al. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma 2007, 24:1545-1557.
27. Xiong Y., Lu D., Qu C., et al. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J Neurosurg 2008, 109:510-521.
28. Martínez-Estrada O.M., Rodríguez-Millán E., González-De Vicente E., et al. Erythropoietin protects the invitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 2003, 18:2538-2544.
29. Kim H., Lee J.M., Park J.S., et al. Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier. Biochem Biophys Res Commun 2008, 372:243-248.
30. Yeh W.L., Lu D.Y., Lin C.J., et al. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol 2007, 72:440-449.
31. Stover J.F., Dohse N.K., Unterberg A.W. Bradykinin 2 receptor antagonist LF 16-0687Ms reduces posttraumatic brain edema. Acta Neurochir Suppl 2000, 76:171-175.
32. Ivashkova Y., Svetnitsky A., Mayzler O., et al. Bradykinin B2 receptor antagonism with LF 18-1505T reduces brain edema and improves neurological outcome after closed head trauma in rats. J Trauma 2006, 61:879-885.
33. Tósaki A., Szerdahelyi P., Joó F. Treatment with ranitidine of ischemic brain edema. Eur J Pharmacol 1994, 264:455-458.
34. Stokely M.E., Orr E.L. Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice. J Neurotrauma 2008, 25:52-61.
35. Chodobski A., Zink B.J., Szmydynger-Chodobska J. Blood-brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res 2011, 2:492-516.
36. Neuhaus W., Burek M., Wunder C., et al. Novel strategies to restore blood-brain barrier integrity after brain injury. Blood Brain Barrier: New Research 2012, 145-172. Nova Science, Hauppauge, NY. 1st ed. P.A. Montenegro, S.M. Juárez (Eds.).
37. Xiong Y., Mahmood A., Chopp M. Animal models of traumatic brain injury. Nature Rev Neurosci 2013, 14:128-142.
38. Dixon C.E., Clifton G.L., Lighthall J.W., et al. A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 1991, 39:253-262.
39. Marmarou A., Foda M.A., van den Brink W., et al. A new model of diffuse brain injury in rats. I: Pathophysiology and biomechanics. J Neurosurg 1994, 80:291-300.
40. Dixon C.E., Lyeth B.G., Povlishock J.T., et al. A fluid percussion model of experimental brain injury in the rat. J Neurosurg 1987, 67:110-119.
41. Cernak I., Savic J., Malicevic Z., et al. Involvement of the central nervous system in the general response to pulmonary blast injury. J Trauma 1996, 40(3 suppl):S100-S104.
42. Kovacs S.K., Leonessa F., Ling G.S. Blast TBI models, neuropathology, and implications for seizure risk. Front Neurol 2014, 5:47.
43. Angoa-Perez M., Kane M.J., Briggs D.I., et al. Animal models of sports-related head injury: bridging the gap beteen pre-clinical research and clinical reality. J Neurochem 2014, 129:916-931.
44. Murakami K., Kondo T., Yang G., et al. Cold injury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog Neurobiol 1999, 57:289-299.
45. Kochanek P.M., Marion D.W., Zhang W., et al. Severe controlled cortical impact in rats: assessment of cerebral edema, blood flow, and contusion volume. J Neurotrauma 1995, 12:1015-1025.
46. Shapira Y., Shohami E., Sidi A., et al. Experimental closed head injury in rats: mechanical, pathophysiologic, and neurologic properties. Crit Care Med 1988, 16:258-265.
47. Lundblad C., Grande P.O., Bentzer P. A mouse model for evaluation of capillary perfusion, microvascular permeability, cortical blood flow, and cortical edema in the traumatized brain. J Neurotrauma 2004, 21:741-753.
48. Chen Y., Constantini S., Trembovler V., et al. An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 1996, 13:557-568.
49. Wang Y., Wei Y., Oguntayo S., et al. Tightly coupled repetitive blast-induced traumatic brain injury: development and characterization in mice. J Neurotrauma 2011, 28:2171-2183.
50. Gennarelli T.A., Thibault L.E., Adams J.H., et al. Diffuse axonal injury and traumatic coma in the primate. Ann Neurol 1982, 12:564-574.
51. Morrison B., Saatman K.E., Meaney D.F., et al. Invitro central nervous system models of mechanically induced trauma: a review. J Neurotrauma 1998, 15:911-928.
52. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res Bull 1999, 49:377-391.
53. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat Rev Neurosci 2004, 5:146-156.
54. Stichel C.C., Niermann H., D'Urso D., et al. Basal membrane-depleted scar in lesioned CNS: characteristics and relationships with regenerating axons. Neuroscience 1999, 93:321-333.
55. Parmentier-Batteur S., Finger E.N., Krishnan R., et al. Attenuation of scratch-induced reactive astrogliosis by novel EphA4 kinase inhibitors. J Neurochem 2011, 118:1016-1031.
56. Cory G. Scratch-wound assay. Methods Mol Biol 2011, 769:25-30.
57. Shih Y.T., Wang M.C., Peng H.H., et al. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma. Cell Signal 2012, 24:779-793.
58. Jowers C.T., Taberner A.J., Dragunow M., et al. The cell injury device: a high-throughput platform for traumatic brain injury research. J Neurosci Methods 2013, 218:1-8.
59. O'Leary A.P., Fox J.M., Pullar C.E. Beta-Adrenoceptor activation reduces both dermal microvascular endothelial cell migration via acAMP-dependent mechanism and wound angiogenesis. J Cell Physiol 2014, in press.
60. Lackler K.P., Cochran D.L., Hoang A.M., et al. Development of an invitro wound healing model for periodontal cells. J Periodontol 2000, 71:226-237.
61. Laplaca M.C., Lee V.M., Thibault L.E. An invitro model of traumatic neural injury: loading rate-dependent changes in acute cytosolic calcium and lactate dehydrogenase release. J Neurotrauma 1997, 14:355-368.
62. Morrison B.I., Meaney D.F., McIntosh T.K. Mechanical characterization of an invitro device designed to quantitatively injure living brain tissue. Ann Biomed Eng 1998, 26:381-390.
63. Ellis E.F., McKinney J.S., Willoughby K.A., et al. A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astrocytes. J Neurotrauma 1995, 12:325-339.
64. Cargill R.S., Thibault L.E. Acute alterations in [Ca2+]i in NG108-15 cells subjected to high strain rate deformation and chemical hypoxia: an invitro model for neural trauma. J Neurotrauma 1996, 13:395-407.
65. Augustine C., Cepinskas G., Fraser D.D. Traumatic injury elicits JNK-mediated human astrocyte retraction invitro. Neuroscience 2014, 274:1-10. Canadian Critical Care Translational Biology Group.
66. Bell J.D., Ai J., Chen Y., et al. Mild invitro trauma induces rapid Glur2 endocytosis, robustly augments calcium permeability and enhances susceptibility to secondary excitotoxic insult in cultured Purkinje cells. Brain 2007, 130:2528-2542.
67. Berrout J., Jin M., O'Neil R.G. Critical role of TRPP2 and TRPC1 channels in stretch-induced injury of blood-brain barrier endothelial cells. Brain Res 2012, 1436:1-12.
68. de Rivero Vaccari J.P., Minkiewicz J., Wang X., et al. Astrogliosis involves activation of retinoic acid-inducible gene-like signaling in the innate immune response after spinal cord injury. Glia 2012, 60:414-421.
69. McKinney J.S., Willoughby K.A., Liang S., et al. Stretch-induced injury of cultured neuronal, glial, and endothelial cells. Effect of polyethylene glycol-conjugated superoxide dismutase. Stroke 1996, 27:934-940.
70. Panzer M.B., Wood G.W., Bass C.R. Scaling in neurotrauma: how do we apply animal experiments to people?. Exp Neurol 2014, 261C:120-126.
71. Webster G.D., Rzigalinski B.A., Gabler H.C. Development of an improved injury device for neural cell cultures. Biomed Sci Instrum 2008, 44:483-488.
72. Zhang L., Yang K.H., King A.I. Biomechanics of neurotrauma. Neurol Res 2001, 23:144-156.
73. Geddes D.M., Cargill R.S. An invitro model of neural trauma: device characterization and calcium response to mechanical stretch. J Biomech Eng 2001, 123:247-255.
74. Geddes D.M., Cargill R.S., LaPlaca M.C. Mechanical stretch to neurons results in a strain rate and magnitude-dependent increase in plasma membrane permeability. J Neurotrauma 2003, 20:1039-1049.
75. Naruse K., Yamada T., Sai X.R., et al. Pp125FAK is required for stretch dependent morphological response of endothelial cells. Oncogene 1998, 17:455-463.
76. Naruse K., Yamada T., Sokabe M. Involvement of SA channels in orienting response of cultured endothelial cells to cyclic stretch. Am J Physiol 1998, 274:H1532-H1538.
77. Sasamoto A., Nagino M., Kobayashi S., et al. Mechanotransduction by integrin is essential for IL-6 secretion from endothelial cells in response to uniaxial continuous stretch. Am J Physiol Cell Physiol 2005, 288:C1012-C1022.
78. Lusardi T.A., Rangan J., Sun D., et al. A device to study the initiation and propagation of calcium transients in cultured neurons after mechanical stretch. Ann Biomed Eng 2004, 32:1546-1558.
79. Geddes-Klein D.M., Schiffman K.B., Meaney D.F. Mechanisms and consequences of neuronal stretch injury invitro differ with the model of trauma. J Neurotrauma 2006, 23:193-204.
80. LaPlaca M.C., Cullen D.K., McLoughlin J.J., et al. High rate shear strain of three-dimensional neural cell cultures: a new invitro traumatic brain injury model. J Biomech 2005, 38:1093-1105.
81. Cullen D.K., Vernekar V.N., LaPlaca M.C. Trauma-induced plasmalemma disruptions in three-dimensional neural cultures are dependent on strain modality and rate. J Neurotrauma 2011, 28:2219-2233.
82. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 1991, 37:173-182.
83. Bahr B.A. Long-term hippocampal slices: a model system for investigating synaptic mechanisms and pathologic processes. J Neurosci Res 1995, 42:294-305.
84. Crain S.M. Development of specific synaptic network functions in organotypic central nervous system (CNS) cultures: implications for transplantation of CNS neural cells invivo. Methods 1998, 16:228-238.
85. Finley M., Fairman D., Liu D., et al. Functional validation of adult hippocampal organotypic cultures as an invitro model of brain injury. Brain Res 2004, 1001:125-132.
86. Frantseva M., Perez Velazquez J.L., Tonkikh A., et al. Neurotrauma/neurodegeneration and mitochondrial dysfunction. Prog Brain Res 2002, 137:171-176.
87. Frantseva M.V., Kokarovtseva L., Perez Velazquez J.L. Ischemia-induced brain damage depends on specific gap-junctional coupling. J Cereb Blood Flow Metab 2002, 22:453-462.
88. Schlessinger A.R., Cowan W.M., Gottlieb D.I. An autoradiographic study of the time of origin and the pattern of granule cell migration in the dentate gyrus of the rat. J Comp Neurol 1975, 159:149-175.
89. Bayer S.A. Neuron production in the hippocampus and olfactory bulb of the adult rat brain: addition or replacement?. Ann NY Acad Sci 1985, 457:163-172.
90. Dailey M.E., Buchanan J., Bergles D.E., et al. Mossy fiber growth and synaptogenesis in rat hippocampal slices invitro. J Neurosci 1994, 14:1060-1078.
91. Frotscher M., Zafirov S., Heimrich B. Development of identified neuronal types and of specific synaptic connections in slice cultures of rat hippocampus. Prog Neurobiol 1995, 45:143-164.
92. Gähwiler B.H., Capogna M., Debanne D., et al. Organotypic slice cultures: a technique has come of age. Trends Neurosci 1997, 20:471-477.
93. Holopainen I.E., Lauren H.B. Neuronal activity regulates GABAA receptor subunit expression in organotypic hippocampal slice cultures. Neuroscience 2003, 118:967-974.
94. Holopainen I.E. Organotypic hippocampal slice cultures: a model system to study basic cellular and molecular mechanisms of neuronal cell death, neuroprotection, and synaptic plasticity. Neurochem Res 2005, 12:1521-1528.
95. Kim H., Kim E., Park M., et al. Organotypic hippocampal slice culture from the adult mouse brain: a versatile tool for translational neuropsychopharmacology. Prog Neuropsychopharmacol Biol Psychiatry 2013, 41:36-43.
96. Danzer S.C. Postnatal and adult neurogenesis in the development of human disease. Neuroscientist 2008, 14:446-458.
97. Chao H.M., Chen I.L., Liu J.H. S-allyl L-cysteine protects the retina against kainate excitotoxicity in the rat. Am J Chin Med 2014, 42:693-708.
98. Harris K., Armstrong S.P., Campos-Pires R., et al. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site. Anesthesiology 2013, 119:1137-1148.
99. Schoeler M., Loetscher P.D., Rossaint R., et al. Dexmedetomidine is neuroprotective in an invitro model for traumatic brain injury. BMC Neurol 2012, 12:20.
100. Engel T., Sanz-Rodgriguez A., Jimenez-Mateos E.M., et al. CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizures. Brain 2013, 136:577-592.
101. Puyal J., Ginet V., Clarke P.G. Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection. Prog Neurobiol 2013, 105:24-48.
102. Ito Y., Ito M., Takagi N., et al. Neurotoxicity induced by amyloid beta-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-L-cysteine, a garlic compound. Brain Res 2003, 985:98-107.
103. Park S.J., Jung H.J., Son M.S., et al. Neuroprotective effects of INM-176 against lipopolysaccharide-induced neuronal injury. Pharmacol Biochem Behav 2012, 101:427-433.
104. Nam K.N., Kim K.P., Cho K.H., et al. Prevention of inflammation-mediated neurotoxicity by butylidenephthalide and its role in microglial activation. Cell Biochem Funct 2013, 31:707-712.
105. Yu Z., Tsay C., Lacour S.P., et al. Stretchable microelectrode arrays-a tool for discovering mechanisms of functional deficits underlying traumatic brain injury and interfacing neurons with neuroprosthetics. Conf Proc IEEE Eng Med Biol Soc 2006, (Suppl):6732-6735.
106. Hughes R.H., Silva V.A., Ahmed I., et al. Neuroprotection by genipin against reactive oxygen and reactive nitrogen species-mediated injury in organotypic hippocampal slice cultures. Brain Res 2014, 1543:308-314.
107. Adamchik Y., Frantseva M.V., Weisspapir M., et al. Methods to induce primary and secondary traumatic damage in organotypic hippocampal slice cultures. Brain Res Brain Res Protoc 2000, 5:153-158.
108. Coburn M., Maze M., Franks N.P. The neuroprotective effects of xenon and helium in an invitro model of traumatic brain injury. Crit Care Med 2008, 36:588-595.
109. Bellander B.M., Bendel O., Von Euler G., et al. Activation of microglial cells and complement following traumatic injury in rat entorhinal-hippocampal slice cultures. J Neurotrauma 2004, 21:605-615.
110. Morrison B., Cater H.L., Benham C.D., et al. An invitro model of traumatic brain injury utilising two-dimensional stretch of organotypic hippocampal slice cultures. J Neurosci Methods 2006, 150:192-201.
111. Chen Y.C., Smith D.H., Meaney D.F. In-vitro approaches for studying blast-induced traumatic brain injury. J Neurotrauma 2009, 26:861-876.
112. Effgen G.B., Hue C.D., Vogel E., et al. A multiscale approach to blast neurotrauma modeling: II: Methodology for inducing blast injury to invitro models. Front Neurol 2012, 3:23.
113. Hue C.D., Cao S., Dale Bass C.R., et al. Repeated primary blast injury causes delayed recovery, but not additive disruption, in an invitro blood-brain barrier model. J Neurotrauma 2014, 31:951-960.
114. Hue C.D., Cao S., Haider S.F., et al. Blood-brain barrier dysfunction after primary blast injury invitro. J Neurotrauma 2013, 30:1652-1663.
115. Noraberg J., Poulsen F.R., Blaabjerg M., et al. Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord 2005, 4:435-452.
116. Dollé J.P., Morrison B., Schloss R.S., et al. An organotypic uniaxial strain model using microfluidics. Lab Chip 2013, 13:432-442.
117. Hoppe J.B., Haag M., Whalley B.J., et al. Curcumin protects organotypic hippocampal slice cultures from Aβ1-42-induced synaptic toxicity. Toxicol Invitro 2013, 27:2325-2330.
118. Neuhaus W., Burek M., Djuzenova C.S., et al. Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells. Neurosci Lett 2012, 506:44-49.
119. Riento K., Ridley A.J. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003, 4:446-456.
120. Katoh K., Kano Y., Amano M., et al. Rho-kinase-mediated contraction of isolated stress fibers. J Cell Biol 2001, 153:569-584.
121. Kuhlmann C.R., Tamaki R., Gamerdinger M., et al. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 2007, 102:501-507.
122. Hicks K., O'Neil R.G., Dubinsky W.S., et al. TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress. Am J Physiol Cell Physiol 2010, 298:C1583-C1593.
123. Kuhlmann C.R., Lessmann V., Luhmann H.J. Fluvastatin stabilizes the blood-brain barrier invitro by nitric oxide-dependent dephosphorylation of myosin light chains. Neuropharmacology 2006, 51:907-913.
124. Kuhlmann C.R., Zehendner C.M., Gerigk M., et al. MK801 blocks hypoxic blood-brain-barrier disruption and leukocyte adhesion. Neurosci Lett 2009, 449:168-172.
125. Luh C., Kuhlmann C.R., Ackermann B., et al. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. J Neurochem 2010, 112:1015-1025.
126. Reichardt H.M., Gold R., Lühder F. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Expert Rev Neurother 2006, 6:1657-1670.
127. Poungvarin N. Steroids have no role in stroke therapy. Stroke 2004, 35:229-230.
128. Dietrich J., Rao K., Pastorino S., et al. Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol 2011, 4:233-242.
129. Blecharz K.G., Drenckhahn D., Förster C.Y. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J Cereb Blood Flow Metab 2008, 28:1139-1149.
130. Förster C., Silwedel C., Golenhofen N., et al. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine invitro system. J Physiol 2005, 565:475-486.
131. Förster C., Kahles T., Kietz S., et al. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J Physiol 2007, 580:937-949.
132. Hartmann C., El-Gindi J., Lohmann C., et al. TIMP-3: a novel target for glucocorticoid signaling at the blood-brain barrier. Biochem Biophys Res Commun 2009, 390:182-186.
133. Kleinschnitz C., Blecharz K., Kahles T., et al. Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. Stroke 2011, 42:1081-1089.
134. Thal S.C., Schaible E.V., Neuhaus W., et al. Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury. Crit Care Med 2013, 41:1305-1315.
135. Collino M., Patel N.S., Thiemermann C. PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury. Ther Adv Cardiovasc Dis 2008, 2:179-197.
136. Mysiorek C., Culot M., Dehouck L., et al. Peroxisome proliferator -activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier. Curr Neurovasc Res 2009, 6:181-193.
137. Neuhaus W. PPARα agonists stabilize the blood-brain barrier after invitro stroke by inhibition of MMP and proteasome activity. Symposium. Beating the Blood-Brain and other Blood Barriers. Lecture at the Beating the Blood-Brain Barrier Symposium. Lisbon, Portugal; February 6-8,2013.
138. Zhou Y., Yang L., Ma A., et al. Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α. Neuropharmacology 2012, 63:242-249.
139. Besson V.C., Chen X.R., Plotkine M., et al. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury. Neurosci Lett 2005, 388:7-12.
140. Chen X.R., Besson V.C., Palmier B., et al. Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury. J Neurotrauma 2007, 24:1119-1131.
141. Thal S.C., Heinemann M., Luh C., et al. Pioglitazone reduces secondary brain damage after experimental brain trauma by PPAR-γ-independent mechanisms. J Neurotrauma 2011, 28:983-993.
142. Sauerbeck A., Gao J., Readnower R., et al. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury. Exp Neurol 2011, 227:128-135.
143. Maeshiba Y., Kiyota Y., Yamashita K., et al. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung 1997, 47:29-35.